Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Catherine Longworth
The medtech M&A deal count soared in October with a total of 30 deals announced and closed in the month. It was an especially busy month for the orthopedics sector, with a number of high profile deals inked.
Regenerative medicine firm Tissue Regenix has named Steve Couldwell as its new CEO, following the departure of Anthony Odell, who led the group for over a decade.
Cambridge Epigenetix Ltd. (CEGX) has appointed two new senior executives to help drive development of its epigenetics-based diagnostic technologies. Hayden Jeffreys joins the company as COO and Joanne Mason as vice president of biomarker discovery.
Molecular diagnostics company genedrive has severed ties with its India distributor Xcleris Labs following problems with its MTB/RIF test for tuberculosis.
In this edition of Device Week, Medtech Insight’s Tina Tan chats to Catherine Longworth about the recent surge in M&A deal-making and wonder if this would impact 2017’s overall outlook. They also chat about Merck’s ambitions to be an all-round leader in fertility treatment, for both drugs and devices and what makes Ireland continue to be an attractive medtech hub for generating innovation.
Philips is teaming up with NHS Glasgow & Clyde and NHS Lothian to pilot a national digital pathology service for Scotland. The pilot will last up to 12 months and is designed to establish a digitized national pathology service across Scottish hospitals.